2022 Volume 43 Issue 3 Pages 70-74
Purpose: The purpose of this study is to investigate the effect of wavelength-controlling lenses (NeoContrast®) on contrast sensitivity in amblyopic patients.
Methods: This study included 12 patients (9.2 ± 4.1 years) with amblyopia who have previously been treated for the condition. Contrast sensitivity was measured using the CSV-1000HGTi (Vector Vision) in three conditions: healthy eye under refractive correction, amblyopic eye under refractive correction, and amblyopic eye under refractive correction using NeoContrast® lenses.
Results: The contrast sensitivity of amblyopic eyes under refractive correction using NeoContrast® lenses was significantly higher than that of amblyopic eyes under refractive correction (p = 0.01); the improvement in contrast sensitivity was comparable to that of healthy eyes under refractive correction.
Conclusions: The results suggest that NeoContrast® lenses may contribute to the improvement of contrast sensitivity in amblyopic eyes.
